{
    "2015-10-12": [
        "Merck also down 2% in wake of Lilly decision to scrap evacetrapib but Regeneron up 2.5%",
        "Volume Alert - MRK 50.23 Merck & Company",
        "Premarket Biotech Digest: Understanding Multiple Sclerosis, Gilead's Hep C Sales, AstraZeneca Halts"
    ]
}